[EL3-6A] Optimal induction approaches for follicular lymphoma: are we moving toward a precision approach?
Jonathan W. Friedberg, M.D., is Samuel Durand Professor of Medicine at the University of Rochester, and Director of the James P. Wilmot Cancer Institute.
Dr. Friedberg received his medical degree from Harvard Medical School. His postgraduate training included an internship and residency at Massachusetts General Hospital. He also completed a medical oncology and hematology fellowship at Dana-Farber/Partners Cancer Care in Boston. Dr. Friedberg also has an M.M.Sc. degree from Harvard Medical School in clinical investigation.
His research interests focus on development of novel therapies for patients with lymphoma. He is chair of the lymphoma committee in the SWOG NCTN group, and serves as associate editor for hematological malignancies at Journal of Clinical Oncology. He was awarded the Scholar in Clinical Research award from the Leukemia & Lymphoma Society, and has chaired the education program of the American Society of Hematology annual meeting.
Dr. Friedberg received his medical degree from Harvard Medical School. His postgraduate training included an internship and residency at Massachusetts General Hospital. He also completed a medical oncology and hematology fellowship at Dana-Farber/Partners Cancer Care in Boston. Dr. Friedberg also has an M.M.Sc. degree from Harvard Medical School in clinical investigation.
His research interests focus on development of novel therapies for patients with lymphoma. He is chair of the lymphoma committee in the SWOG NCTN group, and serves as associate editor for hematological malignancies at Journal of Clinical Oncology. He was awarded the Scholar in Clinical Research award from the Leukemia & Lymphoma Society, and has chaired the education program of the American Society of Hematology annual meeting.
Abstract password authentication.
Password is written on a program and abstract book.